![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM)
|
NeoVista Inc |
|
|
Debt |
|
|
|
|
NeoVista Inc |
|
|
Series E |
|
|
|
|
SironRx Therapeutics Inc |
|
Developer of regenerative therapies for the treatment of dermal wound repair |
Venture |
|
|
|
|
King Pharmaceuticals |
|
|
Acquisition |
USD 3,600,000,000 |
|
|
|
Ipierian Inc |
|
Biopharmaceutical company using patient-derived induced pluripotent stem cells for drug discovery. |
Series B |
|
|
|
ZyStor Therapeutics Inc |
|
|
Acquisition |
USD 115,000,000 |
|
|
|
Achillion Pharmaceuticals Inc |
|
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
Venture |
|
|
|
ZocDoc Inc |
|
Provider of physician finder and appointment booking services. |
Series B |
|
|
|
1life Healthcare Inc |
|
A healthcare company focuses on designing innovative health care solutions. |
Venture |
USD 15,000,000 |
|
|
|
Facet Biotech |
|
|
Acquisition |
USD 450,000,000 |
|
|
|
Visiogen Inc |
|
A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. |
Acquisition |
USD 400,000,000 |
|
|
|
Direct Flow Medical Inc |
|
Medical device developer |
Series C |
|
|
|
ValenTx Inc |
|
Developer of a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. |
Series B |
|
|
|
Pique Therapeutics Inc |
|
Biotechnology company seeking to become the leader in therapeutic vaccines, focused initially on the treatment of cancer |
Series A |
|
|
|
|
Elixir Pharmaceuticals Inc |
|
|
Series D |
|
|
|
|
Visiogen Inc |
|
A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. |
Series D |
USD 40,000,000 |
|
|
|
Foundation Radiology Group Inc |
|
Provider of radiology solutions to hospitals. |
Series A |
|
|
|
|
1life Healthcare Inc |
|
A healthcare company focuses on designing innovative health care solutions. |
N/A |
USD 8,000,000 |
|
|
|
Actinobac Biomed Inc |
|
|
Venture |
|
|
|
|
NeoVista Inc |
|
|
Series D |
|
|